Although photoreceptor defects can occur following the resolution of chronic SRF in conditions such as chronic central serous chorioretinopathy and long-standing RD [22,23], in malignant hypertension where SRF or IRF respond early to systemic treatment, their impact on visual prognosis is debatable. This evidence concerns the gene TRIM63 and malignant hypertension.